Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
ACTUALITES

MSD Congratulates Senegal on the Successful Launch of its National Immunisation Programme for Human-Papillomavirus (HPV)


Alwihda Info | Par APO - 5 Novembre 2018 modifié le 1 Janvier 1970


MSD ([www.MSD.co.za](http://www.msd.co.za/)), known as Merck & Co., Inc., (NYSE: MRK) in the United States and Canada, congratulates Senegal on the successful launch of the National Immunisation Programme (NIP) for the Human-Papillomavirus (HPV – the main cause of cervical cancer).[1] Approximately 530 000 women are diagnosed with cervical cancer around the world each year.[2] In Sub-Saharan […]

MSD ([www.MSD.co.za](http://www.msd.co.za/)), k...

Source : http://feedproxy.google.com/~r/Appa-sourceTheAfric...